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Abstract 
 
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system whose cause is 
still unknown. The disease course shows great inter- and intra-individual variability and this 
results in insecurity of diagnosis and prognosis. A well-founded knowledge of the natural 
history of MS, however, is an important prerequisite for developing adequate strategies for 
therapy and research.  In order to increase our understanding we developed a segmented 
regression model which extracts three main characteristics of the time course of this complex 
disease from natural history data. For each individual patient this model determines baseline 
disability (as measured by the Expanded Disability Status Scale = EDSS), the time point where 
the disease starts to progress and the slope of this progression. The model is applied to data of 
patient registries from all over the world that are pooled in the database of the Sylvia Lawry 
Centre for Multiple Sclerosis Research (SLCMSR). The analyses used a random subsample of 
the entire database and were restricted to patients seen from onset of MS with time series of at 
least three years. Thereby we were able to avoid some of the problems related to missing data. 
Our results revealed a weak negative correlation between time to progression (change point) 
and slope of progression for this group of patients, i.e. those patients who do progressed later 
and remained stable for a longer time developed disability more slowly than those who 
progressed earlier. For the two parameters and their interaction we did not find an influence of 
basic covariates like gender, disease course and mono- or poly-symptomatic disease onset. 
According to the SLCMSR Policy these results will be subjected to a validation using an 
independent "validation dataset". This remains to be done. 
 
1 Introduction 
 
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system. It is 
influenced by genetic and environmental factors but its cause is still unknown. 
Considerable research has revealed a great and to a large extent unexplained 
heterogeneity in disease course which results in insecurity of diagnosis and prognosis. 
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A good understanding of the natural course of MS is, however, an important basis for 
developing adequate strategies for therapy and research.  The long-term evolution of 
MS in an individual patient usually shows one or two phases. After an initial, more or 
less stable phase (which can also be absent) disability increases steadily through the 
accumulation of partially reversible impairments of the central nervous system. The 
change point between stable and progressive phase is usually not easily determined. 
 
Analyses of the natural course of MS are usually performed using survival methods for 
the time to reach sustained progression or critical disability levels (e.g. Weinshenker et 
al., 1991; Amato et al., 1999; Confavreux et al., 2003). Several of the older articles find 
themselves in disagreement over the influence of important covariates such as gender, 
age at disease onset, initial symptoms, type of disease course etc. This is partly due to 
the fact that different endpoints/outcome measures were considered but also to the use 
of statistical methods which did not adequately account for interdependencies between 
potential factors of influence. More recent work using comparable endpoints and more 
complex (e.g. multivariate) statistical methods draw similar conclusions with respect to 
the influence of some basic predictors (gender, initial symptoms, type of disease 
course), despite using different data sets. The importance of other covariates, such as 
the number of relapses in a given time interval, is still equivocal (e.g. Weinshenker et 
al., 1991; Confavreux et al. 2000). A Markov model makes clear that the effects of 
some covariates are limited to transitions between specific disease states (Wolfson and 
Confavreux, 1987). As all of these results only allow for very rough predictions for 
categories of patients with remaining high variation within them the challenge is now to 
advance existing and develop new methods enabling more specific forecasts at early 
disease stages. The approach taken here is a step in this direction. 
 
Data for individual MS patients usually consist of time series of neurological measures 
(see Figure 1) implying that survival models neglect valuable information. 
Nevertheless, methods for longitudinal data are rarely applied. Fog and Linneman 
(1970) and Patzold and Pocklington (1982) use regression analyses to choose the best 
fitting among several concurrent regression curves (linear, parabolic, hyperbolic and 
polynomial). Both studies arrive at similar conclusions although their time series are 
based on different neurological scales. On the other hand they result in categories of  
regression curves which are difficult to compare. This also complicates further 
analyses. In order to escape this dilemma we developed a segmented regression model 
which extracts three main characteristics of the time course of disability from natural 
history data. For each patient this model determines baseline disability, the time point 
where progression starts and the slope of this progression. Disability is measured using 
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the Expanded Disability Status Scale (=EDSS), an ordinal scale ranging from zero to 
ten with steps of 0.5. The data stem from a large pooled database of registry data which 
have been donated to the Sylvia Lawry Centre for Multiple Sclerosis Research 
(SLCMSR) by institutions from all over the world (see acknowledgement; Noseworthy 
et al. 2003).  Methodologically our approach ties in with models for detecting change 
points (e.g. Basseville and Nikiforov 1993; Daumer and Neiß 2001) and as regards 
interpretation it is based on widespread assumptions on the underlying physiological 
process (see above). In order to reduce potential difficulties arising from missing values 
and measurement error we restricted the current analysis to patients seen from onset of 
MS with time series of at least three years and three or more visits.  
 
Figure 1 Examples of individual time series of disability as measured by the Extended 
Disability Status Scale (EDSS) and model output (red line). The horizontal arrows 
indicate the baseline EDSS (e0) and the vertical arrows the change point (τ) 
determined by the model. 
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2 Database and patient population 
 
The data have been donated to the SLCMSR from institutions all over the world (see 
acknowledgements). For confidentiality reasons it is not possible to identify the 
individual sources of the data pooled in the SLCMSR database. Moreover, to warrant a 
high quality of statistical analyses performed at the SLCMSR, the database is randomly 
split into two subsets: the open part used for model building and hypotheses generation 
and the closed part is administered by trustees. It is the declared policy of the SLCMSR 
to validate analyses performed on the open part of the database using its closed 
counterpart. The results presented here have not yet undergone this validation 
procedure and have, therefore, to be considered as preliminary. 
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The analyses in this study utilized a random subset of the natural history part of the 
SLCMSR database which in release 003 contains 1628 patients with more than one 
visit. Information was available on the following covariates: gender; age at onset of 
disease [years]; mono- or poly-symptomatic disease onset; duration of MS [months], 
age and EDSS at entry into the study; and disease course (RR: relapsing remitting, SP: 
secondary progressive, RP: relapsing progressive, PP: primary progressive).  
 
The focus of this study were patients seen at onset (N=167), i.e. whose first 
presentation coincided with the onset of MS, and who additionally qualified as valid for 
the analyses. Initially we included all those patients with three or more visits and a time 
series of at least three years after onset (N=93). In order to account for the fact that the 
status five years after onset is an important predictor (e.g. Kurtzke et al. 1977), the 
sample was further reduced after fitting the segmented regression model described 
below. Patients who were censored before the sixth year while still being stable were 
removed from the sample because their status (stable or progressing) at year five was 
unknown. In what follows the resulting group of 62 patients will be termed valid. Two 
thirds of these patients were female (see Table 1) and 40.3% had a mono-symptomatic 
onset. The disease course was relapsing remitting in 29.0% of the cases, 51.6% were 
secondary progressive, 8.1% relapsing progressive, one woman (1.6%) had a primary 
progressive course and for 9.7% the information was missing.  
 
3 Modelling approach  and statistical analyses 
 
In order to capture the basic characteristics of the disease course a segmented 
regression model with change-point τ was chosen: 
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Our approach restricted the slope of the first regression line to be equal to zero (α0=0) 
and that of the second to be positive (α>0). Thus, for each individual time series (i=1, 
.., N) three clinically important characteristics were determined: (i) the baseline EDSS 
e0 in the first segment, (ii) the time point τ where progression starts (change point) and 
(iii) the slope α of this progression in the second segment (Figure 1). The ML 
estimation of these model parameters is equivalent to a non-linear L2 approximation 
problem and can be solved analytically (cf. Küchenhoff, 1997). With n data points of a 
times series and k possible change points there exists a maximum of (O(nk)) local 
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minima which can be determined explicitly. The algorithm determining the model 
parameters was programmed using ActivePerl (1996-2002). 
 
These model parameters and their relation were then subjected to statistical analyses. 
The influence of covariates on α and τ, respectively, was investigated using multiple 
regression analyses and the simultaneous influence on both parameters was studied 
with multivariate methods. Logistic regression was employed to identify differences 
between subgroups of patients. Statistical analyses were conducted using SPLUS 6.0 
(1988-2000) and SPSS 11.0 (2001) both for Windows. 
 
4 Results 
 
As can be seen from Table 1, the 167 patients seen at onset developed MS at an earlier 
age and tended to have a more severe course than those seen 4.3±6.7 years (mean±SD, 
N=1461) after the onset of MS. The 62 valid patients who were used for further 
analyses form a representative subset (Table 1). 
 
Table 1. Characteristics of study population. Patients seen at onset of MS are compared to 
those seen only later (t-test). Sixty-two patients seen at onset proofed valid for further 
analyses (for details see “Database and patient population”). 
 
 Seen at onset Seen later P-value 
 
Number – total 
                Women 
 
167 
71.3% 
(119) 
 
62 
67.7% 
(42) 
 
1461 
64.6% 
(944) 
 
-- 
-- 
Age at onset of MS 
- mean ± SD [years] 
- median, range [y] 
 
 
28.3 ± 
9.7 
26, 12-54 
 
28.6 ± 
9.4 
27, 12-54 
 
30.9 ± 10.0 
30, 6-72 
 
0.0009 
 
Age at 1st presentation 
- mean ± SD [years] 
- median, range [y] 
 
 
28.3 ± 
9.7 
26, 12-54 
 
28.6 ± 
9.4 
27, 12-54 
 
35.8 ± 11.4 
35, 8-82 
 
< 0.0001 
 
(E)DSS at 1st present. 
- mean ± SD  
- median, range  
 
2.2 ± 1.5 
2.0, 1-8 
 
2.3 ± 1.5 
2.0, 1-8 
 
2.5 ± 1.7 
2.0, 0-8.5 
 
0.029 
 
 
The fact that the distribution of baseline EDSS values (e0) calculated by the model had 
very similar moments to that of the EDSS at first presentation (mean±SD: 2.2 ± 1.5, 
median: 2.0) was reassuring. Assuming that at least some first EDSS values resulted 
from relapses it was not unexpected to find a smaller range for the baseline EDSS (1-6, 
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cf. Table 1) which was determined using more than just the first value. The distribution 
of the time to progression (change point) seems to have to modes (Figure 2a). The 
forty-four patients (71%) who progressed early did so before the fifth year after onset 
of MS (range:0-4), most of them even during the first year (71.4%, median: 0, 
mean±SD: 0.8±1.1 years). The late group progressed after a mean of 7.6±1.4 (±SD, 
median: 7.1, range: 5.6-11). The yearly change in EDSS (slope of disease progression) 
showed a distribution which was highly skewed to the right (median: 0.48, mean ±SD: 
0.67±0.58, range: 0-2.5; Figure 2b), with 56.5% of the patients changing by less than 
0.5 per year on the EDSS scale. 
 
Figure 2 Histograms of a) time to start of disease progression (change point) and b) change in 
EDSS per year as determined by the model.  
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The correlation between time to progression (τ) and yearly EDSS change (α) was weak 
and negative (correlation coefficient of Spearman ρ=-0.36, p=0.0046, Figure 3). For the 
subset of 32 patients with a two-phase course  (τ≠0 and α≠0) the negative correlation 
was slightly higher (ρ=-0.44, p=0.014, Y=2.7-0.3x, R2=0.17). While the negative 
correlation was also slightly increased for women (ρ=-0.46, p=0.003, N=42), patients 
with relapsing remitting (ρ=-0.44, p=0.005, N=18) and secondary progressive course 
(ρ =-0.42, p <0.02, N=32) or with mono-symptomatic onset (ρ =-0.43, p<0.01, N=37), 
it  disappeared for men (ρ =-0.06,  p=0.78, N=20) and patients with poly-symptomatic 
onset (ρ =-0.28, p=0.17, N=25).  
 
However, when the influence of covariates on α and τ respectively was investigated 
using multiple regression analyses and when their simultaneous influence on both 
parameters was studied with multivariate methods we did not find an influence of any 
of these covariates. When searching for differences between those patients progressing 
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from onset (τ=0) and later (τ>0) using logistic regression analysis we as well did not 
discover a dependence on the available covariates. 
 
Figure 3 Relation between time to start of disease progression (change point) and change 
EDSS per year as determined by the model (N=62; Y=0.8-0.06x, R2=0.12).  
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5 Discussion 
 
The time point when MS patients with a non-progressive onset proceed from an initial, 
more or less stable to a progressive phase is usually not easily determined. This hinders 
classifying patients into groups of those remaining stable or progressing either 
immediately or beyond specific time points after onset and using this classification, for 
instance, for making predictions. We therefore developed a model which determines 
this transition point together with the patient’s baseline EDSS level before and the slope 
of disease progression afterwards. This model was then fitted to the individual time 
series of EDSS values of patients seen from disease onset. As the EDSS value five 
years from onset is known to be a predictor of the further development of disability 
(e.g. according to Kurtzke’s five year rule it on average amounts to three quarters of 
that at year 15; Kurtzke et al. 1977) we determined the patients’ status every five years. 
Five years after onset eighteen (29%) of the 62 patients seen at onset were still stable, 
33.9% had progressed after an initial stable phase and 37.1% had progressed 
immediately. Another five years later, only one of the eighteen stable patients had 
remained stable and 13 had progressed (four stable patients were censored without 
progressing). That is, after ten years 1.6% of the original 62 patients were still stable 
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and 91.9% had progressed. This, however, says nothing about the rate of progression of 
these patients. 
 
In order to see whether the time point when progression starts influences its rate we 
investigated the relation between time to progression and change in EDSS per year. The 
results showed a week but significant negative correlation between these two 
parameters for patients seen at disease onset. This implies that those patients who did 
progress later and remained stable for a longer time developed disability more slowly 
than those who progressed earlier. With respect to our goal of facilitating predictions, 
none of our uni- and multivariate analyses found any support for the influence of basic 
covariates like gender, mono- or poly-symptomatic onset and disease course on time 
point and rate of progression or on their interaction. This was not totally unexpected 
because Fog and Linneman (1970) and Patzold and Pocklington (1982) who also apply 
regression analyses to time series of  neurological measures report similar findings. 
 
The results presented here are preliminary in two ways. Firstly, they have not yet 
undergone the validation procedure implemented by the SLCMSR to ensure quality 
standards (see “Database and patient population”). Secondly, the parameter values 
determined by fitting the segmented regression model are, of course, sensitive to the 
noisiness of the data. EDSS time series, especially those from registry databases, are 
known to be influenced by acute attacks which do not reflect the long-term course of 
disability, by inter- and intra-rater variability of measurements and by inconsistencies 
of the EDSS scale itself. Possible effects of this are illustrated in Figure 1b where the 
patient probably presented to the hospital because of a severe relapse (EDSS 5). Taking 
into account the further course, the model determined a baseline EDSS value of about 
three (see arrow, Figure 1b). A clinician, on inspection, may assign a baseline value of 
two. These considerations suggest that it may be worthwhile to subject the time series 
of EDSS values to a pre-editing procedure which implements neurological prior 
knowledge to reduce the unavoidable noise in the data. This in turn would allow to 
make more effective use of the modeling approach described here. 
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